SCHEMBL9707771

SCHEMBL9707771

C=C(CC)c1nc2c(c(=O)n(CCC(=O)OC)c(=O)n2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
AGTR1 P30556 2/20 0.40
AGTR2 P50052 2/20 0.40
LMNA P02545 3/20 0.38
MEN1 O00255 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
TRPC4 Q9UBN4 2/20 0.37
TRPC5 Q9UL62 2/20 0.37
KCNH2 Q12809 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
MAPK1 P28482 1/20 0.37
PPARG P37231 2/20 0.36
POLB P06746 1/20 0.36
BRAF P15056 1/20 0.36
PIK3CG P48736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708321 0.93 ALDH1A1 (0.44) ALDH1A1KDM4EAGTR1AGTR2LMNA
SCHEMBL9707689 0.89 TRPC5 (0.45) ALDH1A1KDM4ETRPC4TRPC5KCNH2
SCHEMBL9708634 0.87 KDM4E (0.46) ALDH1A1KDM4EAGTR1AGTR2PPARG
SCHEMBL9708041 0.86 AGTR1 (0.51) ALDH1A1KDM4EAGTR1AGTR2PPARG
SCHEMBL9707888 0.86 ADORA3 (0.41)
SCHEMBL9708723 0.85 AGTR1 (0.48) ALDH1A1KDM4EAGTR1AGTR2PPARG
SCHEMBL9707971 0.84 HPGD (0.38) AGTR1AGTR2LMNASMN1; SMN2
SCHEMBL9708098 0.83 ALDH1A1 (0.42) ALDH1A1KDM4EAGTR1AGTR2LMNA
SCHEMBL9707710 0.82 MAPT (0.39) ALDH1A1LMNACYP2C9CYP2C19MAPT
SCHEMBL9708704 0.81 KMT2A (0.47) ALDH1A1AGTR1AGTR2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed